Copyright ©ERS Journals Ltd 2008 Population prevalence of COPDFirestone Institute for Respiratory Health, McMaster University, Hamilton, ON, Canada. To the Editors: The study by Shirtcliffe et al. 1 discusses the use of various definitions of abnormal spirometric results to estimate the prevalence of chronic obstructive pulmonary disease in New Zealand and raises a major question that is not addressed in the analyses.
Childhood asthma is common and can lead to a degree of irreversible airflow obstruction in adulthood. In another New Zealand study, based on the Dunedin longitudinal population-based cohort, Sears et al. 2 reported that persistent or relapsing childhood asthma was present in 26.9% of 26-yr-old study subjects. This is not dissimilar to the prevalence of doctor-diagnosed asthma (24%) in subjects undergoing pulmonary function testing in the Wellington study. Rasmussen et al. 3 also reported that airway remodelling, based on an abnormal post-bronchodilator forced expiratory volume in one second/forced vital capacity ratio, determined as a ratio It is likely, therefore, that a proportion of subjects determined by spirometry to have "chronic obstructive pulmonary disease" in the Wellington study 1 have asthma-related impairment of lung function. The prevalence of nonasthma-related chronic obstructive pulmonary disease could be determined by excluding subjects with a history of doctor-diagnosed asthma, and if so I suspect the actual prevalence of chronic obstructive pulmonary disease, especially in the younger age groups, reported by Shirtcliffe et al. 1 as 5.6% in those aged <40 yrs and 12% among nonsmokers, would then be significantly lower than reported. REFERENCES
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||